login
login

Europe Daily Bulletin No. 8655

28 February 2004
Contents Publication in full By article 46 / 55
ECONOMIC INTERPENETRATION / (eu) pharmaceuticals

According to The Wall Street Journal, the Swiss company NOVARTIS is undergoing preliminary talks with AVENTIS in order to bring it help against the hostile takeover bid from SANOFI-SYNTHELABO (see EI of 28 January). Furthermore, AVENTIS is on the point of creating a joint venture with the American fund, BLACKSTONE, with a view to selling it its non-strategic medicines that make a turnover of EUR 1.5 billion.

Contents

A LOOK BEHIND THE NEWS
THE DAY IN POLITICS
GENERAL NEWS
TIMETABLE
ECONOMIC INTERPENETRATION